Brent Shishido
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,765 of the $6,070 with a category attached, or 78.5%. 26 manufacturers reported payments, led by Boston Scientific at 47.7% of the total. Reporting peaked in 2024 at $3,023 and has fallen 59.2% since, to $1,233 in 2025.
Across 87 payments — averaging $69.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Coloplast$609
- Teleflex LLC$314
- KARL Storz Endoscopy-america$285
- Urogen Pharma, Inc.$219
- 180 Medical, Inc.$167
- plus $2K from 20 others
What the payments were for
- Travel & lodging$1,20420%
- Food & beverage$4,76579%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 26 | $2,895 |
| Coloplast | 9 | $609 |
| Teleflex LLC | 2 | $314 |
| KARL Storz Endoscopy-america | 4 | $285 |
| Urogen Pharma, Inc. | 7 | $219 |
| 180 Medical, Inc. | 4 | $167 |
| Laborie Medical Technologies Corp. | 2 | $154 |
| Johnson & Johnson | 3 | $154 |
| Cook Medical LLC | 5 | $153 |
| Calyxo, Inc. | 1 | $138 |
| Ferring Pharmaceuticals Inc. | 4 | $117 |
| Procept Biorobotics Corporation | 1 | $110 |
| Innovation Technologies Inc | 2 | $110 |
| Astellas Pharma US Inc | 1 | $100 |
| Janssen Scientific Affairs, LLC | 1 | $99 |
| Olympus America Inc. | 1 | $89 |
| Progenics Pharmaceuticals, Inc. | 1 | $80 |
| AbbVie | 3 | $61 |
| Dendreon Pharmaceuticals LLC | 2 | $56 |
| Photocure Inc | 1 | $33 |
| Urovant Sciences Inc | 2 | $28 |
| Tolmar, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Immunitybio, Inc. | 1 | $21 |
| Merck | 1 | $18 |
| Blue Earth Diagnostics | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LithoVue$284
- TITAN$244
- AdVance XP$147
- UroLift$140
- CVAC Aspiration System$138
- GREENLIGHT$130
- GENERAL KIDNEY STONE DISEASE$123
- RYBREVANT$122
- CARVYKTI$122
- Luja Coude$116
- N/A$116
- JELMYTO$115
- AquaBeam Robotic System$110
- Tria Firm$100
How this compares
$6,070 in reported general payments places this provider in the 60th percentile of 79 urology providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxybutynin Chloride ErOxybutynin Chloride | 74 | $1,441 |
| Tamsulosin Hcl | 49 | $308 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $95 |
| Oxycodone Hcl | 19 | $64 |
Paid to pharmacies, not to this prescriber.
Other urology in Omaha
- John BishayOmaha$138K
- Rebecca McCreryOmaha$71K
- Judson DaviesOmaha$67K
- Stefanie BolteOmaha$59K
- Michael FeloneyOmaha$29K
- Andrew TrainerOmaha$12K
- Stephen LeslieOmaha$12K
- Jon MortonOmaha$11K
- Brett HillOmaha$11K
- John HorganOmaha$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.